Literature DB >> 851511

Radiolabelling of Corynebacterium parvum and its distribution in mice.

T E Sadler, W A Cramp, J E Castro.   

Abstract

Corynebacterium parvum was labelled by growing live bacteria in the presence of [3H]thymidine. The bacteria were killed by formalin, washed thoroughly and resuspended at a concentration of 7 mg dry weight/ml. An activity of 1-6 X 10(5) ct/min/0-1 ml was obtained. The biological properties (inhibition of tumour growth and hepatosplenomegaly) of the labelled C. parvum were compared with those of commercially available vaccine, and were found to be similar. Labelled C. parvum was injected i.v., i.p., or s.c. into normal C57BL mice and the localization of activity determined at 4 h and 1,3,7 and 14 days after injection. After i.v. or i.p. injection, highest counts were recorded in the liver. Moderate activity was found in the spleen, lungs and small gut. After s.c. injection, the majority of radioactive label was detected at the site of injection and little found in other tissues. The distribution of injected C. parvum was also studied in mice bearing Lewis tumour, and was found to be similar to that in normal mice. Moderate amounts of labelled C. parvum were recovered from tumour. There appeared to be no relationship between the antitumour effect of C. parvum given by a particular route of injection and the concentration of C. parvum recovered from the tumour.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 851511      PMCID: PMC2025284          DOI: 10.1038/bjc.1977.50

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  The stripping-film technique of autoradiography.

Authors:  S R PELC
Journal:  Int J Appl Radiat Isot       Date:  1956-11

Review 2.  The blood brain barrier: anatomy and physiology.

Authors:  B L Holman
Journal:  Prog Nucl Med       Date:  1972

3.  Accurate identification of experimental pulmonary metastases.

Authors:  H Wexler
Journal:  J Natl Cancer Inst       Date:  1966-04       Impact factor: 13.506

4.  Depression of delayed-type hypersensitivity by Corynebacterium parvum: mandatory role of the spleen.

Authors:  M T Scott
Journal:  Cell Immunol       Date:  1974-08       Impact factor: 4.868

5.  Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.

Authors:  M T Scott
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

Review 6.  Corynebacterium parvum as an immunotherapeutic anticancer agent.

Authors:  M T Scott
Journal:  Semin Oncol       Date:  1974-12       Impact factor: 4.929

7.  Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat tumors.

Authors:  K SUGIURA; C C STOCK
Journal:  Cancer Res       Date:  1955-01       Impact factor: 12.701

8.  Abrogation of the anti-metastatic activity of C. parvum by antilymphocyte serum.

Authors:  T E Sadler; J E Castro
Journal:  Br J Cancer       Date:  1976-09       Impact factor: 7.640

9.  Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.

Authors:  S E Smith; M T Scott
Journal:  Br J Cancer       Date:  1972-10       Impact factor: 7.640

10.  Synergistic inhibition of mammary carcinoma transplants in A-strain mice by antitumour globulin and C. parvum.

Authors:  M F Woodruff; M P Inchley
Journal:  Br J Cancer       Date:  1971-09       Impact factor: 7.640

View more
  11 in total

1.  Effects of intravenous injection of two different strains of Corynebacterium parvum in the mouse.

Authors:  T E Sadler; P D Jones; J E Castro; I A Lampert
Journal:  Br J Exp Pathol       Date:  1979-12

2.  Lactoferrin protects against development of hepatitis caused by sensitization of Kupffer cells by lipopolysaccharide.

Authors:  M Yamaguchi; M Matsuura; K Kobayashi; H Sasaki; T Yajima; T Kuwata
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Immune adjuvants for chemotherapy or radiotherapy in the 9L rat brain tumor model.

Authors:  C Liu; B F Kimler; R G Evans; R A Morantz
Journal:  J Neurooncol       Date:  1993-02       Impact factor: 4.130

4.  Eicosanoid production by peritoneal and splenic macrophages in mice depleted of bone marrow by 89Sr.

Authors:  Y Shibata; A P Bautista; S N Pennington; J L Humes; A Volkman
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

5.  Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro.

Authors:  G F Webster; J J Leyden; R A Musson; S D Douglas
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

6.  Effect of intracerebrally injected Corynebacterium parvum on implanted brain tumor in mice.

Authors:  J D Kennedy; F K Conley
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

7.  Distribution of intrapleural and intravenous Corynebacterium parvum in humans; 99mTc-, and 131I-labeled bacteria.

Authors:  M Kaufmann; J Marqverson; K E Stanley; C Mouritzen; H Hvid-Hansen
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

8.  Proceedings of the British Association For Cancer Research, 19th Annual General Meeting St. Edmund Hall, University of Oxford 4--6 April, 1978.

Authors: 
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

9.  Intravascular coagulation resulting from intravenous injection of C. parvum in mice.

Authors:  I A Lampert; P D Jones; T E Sadler; J E Castro
Journal:  Br J Cancer       Date:  1977-07       Impact factor: 7.640

10.  Genetic control of Propionibacterium acnes-induced protection of mice against Babesia microti.

Authors:  P R Wood; I A Clark
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.